Drug Shortage Report for CETIRIZINE EXTRA STRENGTH
Report ID | 207328 |
Drug Identification Number | 02517566 |
Brand name | CETIRIZINE EXTRA STRENGTH |
Common or Proper name | Cetirizine Hydrochloride Tablets USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CETIRIZINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | R06AE |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-16 |
Estimated end date | 2023-12-31 |
Actual end date | 2024-01-03 |
Shortage status | Resolved |
Updated date | 2024-01-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-01-04 | English | Compare |
v8 | 2023-12-30 | French | Compare |
v7 | 2023-12-30 | English | Compare |
v6 | 2023-12-17 | French | Compare |
v5 | 2023-12-17 | English | Compare |
v4 | 2023-10-18 | French | Compare |
v3 | 2023-10-18 | English | Compare |
v2 | 2023-10-18 | French | Compare |
v1 | 2023-10-18 | English | Compare |
Showing 1 to 9 of 9